An independent panel of US medical experts voted Monday to recommend Eli Lilly’s experimental Alzheimer’s drug, meaning there could soon be another treatment option available to patients with the devastating brain disorder.
An independent panel of US medical experts voted Monday to recommend Eli Lilly’s experimental Alzheimer’s drug, meaning there could soon be another treatment option available to patients with the devastating brain disorder.